The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects
The review article is aimed at providing a recent update on the use of levosimendan, an inotropic drug in current use for the treatment of heart failure. The review discusses its mechanisms of action, main hemodynamic effects, clinical trials and obtained evidences that have formed the basis of the...
Saved in:
| Main Authors: | N. B. Lebedeva, L. Yu. Chesnokova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2022-05-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2718 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Organoprotective effects of serelaxin in patients with severe decompensated heart failure
by: Z. D. Kobalava, et al.
Published: (2016-09-01) -
A pre - post study to evaluate the clinical efficacy of levosimendan infusion in acute decompensated heart failure
by: K.P. Aiswarya, et al.
Published: (2025-04-01) -
IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE
by: M. V. Lediakhova, et al.
Published: (2018-05-01) -
Levosimendan in lung transplant recipients on VA‑ECMO
by: S. V. Zhuravel, et al.
Published: (2020-04-01) -
CARDIAC PROTECTIVE INOTROPIC THERAPY – OPPORTUNITIES AND PROSPECTIVE OF USING LEVOSIMENDAN IN CARDIAC SURGERY
by: V. V. Pasyuga, et al.
Published: (2018-01-01)